479636-65-2 Usage
Molecular structure
A bicyclic ring system featuring an oxygen atom and two nitrogen atoms, with two carboxylic acid functional groups, a tert-butyl group, and an ethyl group.
Explanation
The compound's unique structure is characterized by the presence of a spiro compound, which includes a central oxygen atom connected to two nitrogen atoms, forming a bicyclic ring system. Additionally, it has two carboxylic acid groups and a tert-butyl and an ethyl ester group.
Explanation
The ester derivative is formed by the reaction of a carboxylic acid with an alcohol, in this case, the tert-butyl and ethyl groups are attached to the central oxygen atom of the spiro compound.
Explanation
The compound's complex structure and multiple functional groups may provide it with unique properties that could be useful in the development of new drugs, synthesis of other organic compounds, or as a component in advanced materials. However, further research and characterization are needed to determine its exact uses and properties.
Explanation
Although the compound's structure and potential applications have been identified, more in-depth studies are needed to fully understand its properties, reactivity, and potential uses in various fields.
Ester derivative
The compound is an ester derivative of the spiro compound.
Potential applications
Pharmaceutical, organic synthesis, and materials science fields.
Need for further study
The exact uses and properties of the compound are not yet known and require additional research.
Check Digit Verification of cas no
The CAS Registry Mumber 479636-65-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,6,3 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 479636-65:
(8*4)+(7*7)+(6*9)+(5*6)+(4*3)+(3*6)+(2*6)+(1*5)=212
212 % 10 = 2
So 479636-65-2 is a valid CAS Registry Number.
479636-65-2Relevant academic research and scientific papers
Novel Compounds as Autotaxin Inhibitors and Pharmaceutical Compositions Comprising the Same
-
Paragraph 0483-0484; 0488-0489, (2018/05/17)
The present invention relates to a novel autotaxin inhibitor compound for preventing and treating disease or symptoms due to an increase in concentration of lysophosphatidic acid or activation of autotaxin. The present invention further relates to a pharmaceutical composition containing the same. The novel compound of the present invention is an autotaxin inhibitor which inhibits production of lysophosphatidic acid, and thus is useful for treating or preventing cardiovascular disease, cancer, metabolic disease, kidney disease, liver disease, inflammatory diseases, nervous disease, respiratory disease, desmoid disease, eye disease, cholestatic symptoms, other types of chronic pruritus or acute, or chronic rejection of transplanted organs.COPYRIGHT KIPO 2017
SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS
-
Page/Page column 60-61, (2010/11/24)
The invention relates to substituted spiro compounds, to methods for producing them, to drugs containing said compounds and to the use of said compounds for producing drugs.
